Artículo

Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients

Camprubí, Daniel; Almuedo Riera, Alex; Martí Soler, Helena; Soriano, Alex; Hurtado, Juan Carlos; Subirà, Carme; Grau Pujol, Berta; Krolewiecki, Alejandro JavierIcon ; Muñoz, José
Fecha de publicación: 11/2020
Editorial: Public Library of Science
Revista: Plos One
ISSN: 1932-6203
Idioma: Inglés
Tipo de recurso: Artículo publicado
Clasificación temática:

Resumen

Ivermectin has recently shown efficacy against SARS-CoV-2 in-vitro. We retrospectively reviewed severe COVID-19 patients receiving standard doses of ivermectin and we compared clinical and microbiological outcomes with a similar group of patients not receiving ivermectin. No differences were found between groups. We recommend the evaluation of high-doses of ivermectin in randomized trials against SARS-CoV-2.
Palabras clave: COVID-19 , SARS-COV-2 , IVERMECTIN
 
Archivos asociados
Thumbnail
 
Tamaño: 364.8Kb
Formato: PDF
.
Licencia
info:eu-repo/semantics/openAccess Excepto donde se diga explícitamente, este item se publica bajo la siguiente descripción: Creative Commons Attribution 2.5 Unported (CC BY 2.5)
Identificadores
URI: http://hdl.handle.net/11336/160651
URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0242184
DOI: http://dx.doi.org/10.1371/journal.pone.0242184
Colecciones
Articulos(CCT - SALTA-JUJUY)
Articulos de CTRO.CIENTIFICO TECNOL.CONICET - SALTA-JUJUY
Citación
Camprubí, Daniel; Almuedo Riera, Alex; Martí Soler, Helena; Soriano, Alex; Hurtado, Juan Carlos; et al.; Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients; Public Library of Science; Plos One; 15; 11; 11-2020; 1-6
Compartir
Altmétricas